Prefrontal changes in the glutamate-glutamine cycle and neuronal/glial glutamate transporters in depression with and without suicide

Journal of Psychiatric Research

Volumn 82, Issue , 2016, Pages 8-15

  Zhao, J ^a   Verwer, R W H ^a   van Wamelen, D J ^a,b   Qi, X R ^a   Gao, S F ^a   Lucassen, P J ^c   Swaab, D F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Anterior cingulate cortex; Depression; Glutamate transporter; Glutamate glutamine cycle; Suicide

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; EXCITATORY AMINO ACID TRANSPORTER; EXCITATORY AMINO ACID TRANSPORTER 3; EXCITATORY AMINO ACID TRANSPORTER 4; GLIAL GLUTAMATE TRANSPORTER; GLUTAMATE AMMONIA LIGASE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; GLUTAMINE; NEURONAL HIGH AFFINITY GLUTAMATE TRANSPORTER; SODIUM COUPLED NEUTRAL AMINO ACID TRANSPORTER 1; SODIUM COUPLED NEUTRAL AMINO ACID TRANSPORTER 2; UNCLASSIFIED DRUG;

ADULT; ANTERIOR CINGULATE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SYNTHESIS; DORSOLATERAL PREFRONTAL CORTEX; FEMALE; GENE EXPRESSION; GLIA CELL; HUMAN; MAJOR DEPRESSION; MALE; MENTAL PATIENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; RNA ISOLATION; SUICIDE; AGED; DEPRESSION; METABOLISM; MIDDLE AGED; NETHERLANDS; PATHOLOGY; POSTMORTEM CHANGE; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMINO ACID TRANSPORT SYSTEM X-AG; DEPRESSION; FEMALE; GLUTAMIC ACID; GLUTAMINE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; POSTMORTEM CHANGES; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; SUICIDE;

EID: 84978682023     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2016.06.017     Document Type: Article

References (59)

1. Arriza, J.L., Kavanaugh, M.P., Fairman, W.A., Wu, Y.N., Murdoch, G.H., North, R.A., Amara, S.G., Cloning and expression of a human neutral amino acid transporter with structural similarity to the glutamate transporter gene family. J. Biol. Chem. 268 (1993), 15329–15332.
2. Ballard, E.D., Ionescu, D.F., Vande Voort, J.L., Niciu, M.J., Richards, E.M., Luckenbaugh, D.A., Brutsche, N.E., Ameli, R., Furey, M.L., Zarate, C.A. Jr., Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. J. Psychiatric Res. 58 (2014), 161–166.
3. Bar-Peled, O., Ben-Hur, H., Biegon, A., Groner, Y., Dewhurst, S., Furuta, A., Rothstein, J.D., Distribution of glutamate transporter subtypes during human brain development. J. Neurochem. 69 (1997), 2571–2580.
4. Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Stat. Soc. 57 (1995), 289–300.
5. Bernard, R., Kerman, I.A., Thompson, R.C., Jones, E.G., Bunney, W.E., Barchas, J.D., Schatzberg, A.F., Myers, R.M., Akil, H., Watson, S.J., Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol. Psychiatr. 16 (2011), 634–646.
6. Broer, A., Brookes, N., Ganapathy, V., Dimmer, K.S., Wagner, C.A., Lang, F., Broer, S., The astroglial ASCT2 amino acid transporter as a mediator of glutamine efflux. J. Neurochem. 73 (1999), 2184–2194.
7. Broer, S., The SLC38 family of sodium-amino acid co-transporters. Pflugers Arch. 466 (2014), 155–172.
8. Burkhalter, J., Fiumelli, H., Erickson, J.D., Martin, J.L., A critical role for system A amino acid transport in the regulation of dendritic development by brain-derived neurotrophic factor (BDNF). J. Biol. Chem. 282 (2007), 5152–5159.
9. Chaudhry, F.A., Lehre, K.P., van Lookeren Campagne, M., Ottersen, O.P., Danbolt, N.C., Storm-Mathisen, J., Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 15 (1995), 711–720.
10. Chen, H.S., Lipton, S.A., The chemical biology of clinically tolerated NMDA receptor antagonists. J. Neurochem. 97 (2006), 1611–1626.
11. Choudary, P.V., Molnar, M., Evans, S.J., Tomita, H., Li, J.Z., Vawter, M.P., Myers, R.M., Bunney, W.E. Jr., Akil, H., Watson, S.J., Jones, E.G., Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 15653–15658.
12. Cotter, D., Mackay, D., Chana, G., Beasley, C., Landau, S., Everall, I.P., Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb. Cortex 12 (2002), 386–394.
13. Cotter, D., Mackay, D., Landau, S., Kerwin, R., Everall, I., Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatr. 58 (2001), 545–553.
14. Danbolt, N.C., Glutamate uptake. Prog. Neurobiol. 65 (2001), 1–105.
15. Davison, A.C., Hinkley, D.V., Bootstrap Methods and Their Application. 1997, Cambridge University Press, Cambridge, UK.
16. Drevets, W.C., Prefrontal cortical-amygdalar metabolism in major depression. Ann. N. Y. Acad. Sci. 877 (1999), 614–637.
17. Drevets, W.C., Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog. Brain Res. 126 (2000), 413–431.
18. Drevets, W.C., Savitz, J., Trimble, M., The subgenual anterior cingulate cortex in mood disorders. CNS Spectr. 13 (2008), 663–681.
19. Duric, V., Banasr, M., Stockmeier, C.A., Simen, A.A., Newton, S.S., Overholser, J.C., Jurjus, G.J., Dieter, L., Duman, R.S., Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. Int. J. Neuropsychopharmacol. Official Sci. J. Coll. Int. Neuropsychopharmacol. 16 (2013), 69–82.
20. Dwivedi, Y., Rizavi, H.S., Conley, R.R., Roberts, R.C., Tamminga, C.A., Pandey, G.N., Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch. Gen. Psychiatr. 60 (2003), 804–815.
21. Egeland, J.A., Sussex, J.N., Suicide and family loading for affective disorders. JAMA 254 (1985), 915–918.
22. Ernst, C., Dumoulin, P., Cabot, S., Erickson, J., Turecki, G., SNAT1 and a family with high rates of suicidal behavior. Neuroscience 162 (2009), 415–422.
23. Ernst, C., Mechawar, N., Turecki, G., Suicide neurobiology. Prog. Neurobiol. 89 (2009), 315–333.
24. Gao, S.F., Bao, A.M., Corticotropin-releasing hormone, glutamate, and gamma-aminobutyric acid in depression. Neuroscientist 17 (2011), 124–144.
25. Grah, M., Mihanovic, M., Ruljancic, N., Restek-Petrovic, B., Molnar, S., Jelavic, S., Brain-derived neurotrophic factor as a suicide factor in mental disorders. Acta Neuropsychiatr., 2014, 1–8.
26. Hawton, K., van Heeringen, K., Suicide. Lancet 373 (2009), 1372–1381.
27. Kugler, P., Schmitt, A., Complementary neuronal and glial expression of two high-affinity glutamate transporter GLT1/EAAT2 forms in rat cerebral cortex. Histochem Cell Biol. 119 (2003), 425–435.
28. Mackenzie, B., Erickson, J.D., Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family. Pflugers Arch. 447 (2004), 784–795.
29. Maeng, S., Zarate, C.A. Jr., The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr. Psychiatr. Rep. 9 (2007), 467–474.
30. Mann, J.J., Currier, D., Medication in Suicide Prevention Insights from Neurobiology of Suicidal Behavior. 2012.
31. Mann, J.J., Currier, D.M., Stress, genetics and epigenetic effects on the neurobiology of suicidal behavior and depression. Eur. Psychiatr. J. Assoc. Eur. Psychiatr. 25 (2010), 268–271.
32. Martinez-Hernandez, A., Bell, K.P., Norenberg, M.D., Glutamine synthetase: glial localization in brain. Science 195 (1977), 1356–1358.
33. Mayberg, H.S., Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br. Med. Bull. 65 (2003), 193–207.
34. Melone, M., Quagliano, F., Barbaresi, P., Varoqui, H., Erickson, J.D., Conti, F., Localization of the glutamine transporter SNAT1 in rat cerebral cortex and neighboring structures, with a note on its localization in human cortex. Cereb. Cortex 14 (2004), 562–574.
35. Milton, I.D., Banner, S.J., Ince, P.G., Piggott, N.H., Fray, A.E., Thatcher, N., Horne, C.H., Shaw, P.J., Expression of the glial glutamate transporter EAAT2 in the human CNS: an immunohistochemical study. Brain Res. Mol. Brain Res. 52 (1997), 17–31.
36. Narushima, K., Kosier, J.T., Robinson, R.G., A reappraisal of poststroke depression, intra- and inter-hemispheric lesion location using meta-analysis. J. Neuropsychiatr. Clin. Neurosci. 15 (2003), 422–430.
37. Ogura, M., Nakamichi, N., Takano, K., Oikawa, H., Kambe, Y., Ohno, Y., Taniura, H., Yoneda, Y., Functional expression of A glutamine transporter responsive to down-regulation by lipopolysaccharide through reduced promoter activity in cultured rat neocortical astrocytes. J. Neurosci. Res. 83 (2006), 1447–1460.
38. Pochini, L., Scalise, M., Galluccio, M., Indiveri, C., Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health. Front. Chem., 2, 2014, 61.
39. Qi, X.R., Zhao, J., Liu, J., Fang, H., Swaab, D.F., Zhou, J.N., Abnormal retinoid and TrkB signaling in the prefrontal cortex in mood disorders. Cereb. Cortex 25:1 (2015), 75–83.
40. Rajkowska, G., Miguel-Hidalgo, J.J., Gliogenesis and glial pathology in depression. CNS Neurol. Disord. Drug Targets 6 (2007), 219–233.
41. Rajkowska, G., Miguel-Hidalgo, J.J., Wei, J., Dilley, G., Pittman, S.D., Meltzer, H.Y., Overholser, J.C., Roth, B.L., Stockmeier, C.A., Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatr. 45 (1999), 1085–1098.
42. Rothstein, J.D., Martin, L., Levey, A.I., Dykes-Hoberg, M., Jin, L., Wu, D., Nash, N., Kuncl, R.W., Localization of neuronal and glial glutamate transporters. Neuron 13 (1994), 713–725.
43. Schioth, H.B., Roshanbin, S., Hagglund, M.G., Fredriksson, R., Evolutionary origin of amino acid transporter families SLC32, SLC36 and SLC38 and physiological, pathological and therapeutic aspects. Mol. Asp. Med. 34 (2013), 571–585.
44. Seminowicz, D.A., Mayberg, H.S., McIntosh, A.R., Goldapple, K., Kennedy, S., Segal, Z., Rafi-Tari, S., Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage 22 (2004), 409–418.
45. Stan, A.D., Ghose, S., Gao, X.M., Roberts, R.C., Lewis-Amezcua, K., Hatanpaa, K.J., Tamminga, C.A., Human postmortem tissue: what quality markers matter?. Brain Res. 1123 (2006), 1–11.
46. Sundberg, B.E., Waag, E., Jacobsson, J.A., Stephansson, O., Rumaks, J., Svirskis, S., Alsio, J., Roman, E., Ebendal, T., Klusa, V., Fredriksson, R., The evolutionary history and tissue mapping of amino acid transporters belonging to solute carrier families SLC32, SLC36, and SLC38. J. Mol. Neurosci. 35 (2008), 179–193.
47. Tani, H., Bandrowski, A.E., Parada, I., Wynn, M., Huguenard, J.R., Prince, D.A., Reimer, R.J., Modulation of epileptiform activity by glutamine and system A transport in a model of post-traumatic epilepsy. Neurobiol. Dis. 25 (2007), 230–238.
48. Torrey, E.F., Webster, M., Knable, M., Johnston, N., Yolken, R.H., The stanley foundation brain collection and neuropathology consortium. Schizophr. Res. 44 (2000), 151–155.
49. Turecki, G., The molecular bases of the suicidal brain. Nat. Rev. Neurosci. 15:12 (2014), 802–816.
50. Utsunomiya-Tate, N., Endou, H., Kanai, Y., Cloning and functional characterization of a system ASC-like Na+-dependent neutral amino acid transporter. J. Biol. Chem. 271 (1996), 14883–14890.
51. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., Speleman, F., Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol., 3, 2002 RESEARCH0034.
52. Varoqui, H., Zhu, H., Yao, D., Ming, H., Erickson, J.D., Cloning and functional identification of a neuronal glutamine transporter. J. Biol. Chem. 275 (2000), 4049–4054.
53. Wang, H., Huang, W., Sugawara, M., Devoe, L.D., Leibach, F.H., Prasad, P.D., Ganapathy, V., Cloning and functional expression of ATA1, a subtype of amino acid transporter A, from human placenta. Biochem. Biophys. Res. Commun. 273 (2000), 1175–1179.
54. Wang, S.S., Kamphuis, W., Huitinga, I., Zhou, J.N., Swaab, D.F., Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Mol. Psychiatr., 13, 2008 786–799, 741.
55. Yamada, K., Wada, S., Watanabe, M., Tanaka, K., Wada, K., Inoue, Y., Changes in expression and distribution of the glutamate transporter EAAT4 in developing mouse Purkinje cells. Neurosci. Res. 27 (1997), 191–198.
56. Yao, D., Mackenzie, B., Ming, H., Varoqui, H., Zhu, H., Hediger, M.A., Erickson, J.D., A novel system A isoform mediating Na+/neutral amino acid cotransport. J. Biol. Chem. 275 (2000), 22790–22797.
57. Zarate, C.A. Jr., Singh, J.B., Carlson, P.J., Brutsche, N.E., Ameli, R., Luckenbaugh, D.A., Charney, D.S., Manji, H.K., A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatr. 63 (2006), 856–864.
58. Zhao, J., Bao, A.M., Qi, X.R., Kamphuis, W., Luchetti, S., Lou, J.S., Swaab, D.F., Gene expression of GABA and glutamate pathway markers in the prefrontal cortex of non-suicidal elderly depressed patients. J. Affect. Disord. 138 (2012), 494–502.
59. Zhao, J., Qi, X.R., Gao, S.F., Lu, J., van Wamelen, D.J., Kamphuis, W., Bao, A.M., Swaab, D.F., Different stress-related gene expression in depression and suicide. J. Psychiatr. Res. 68 (2015), 176–185.